Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - NET INCOME
Net Income ADAP - Adaptimmune Therapeutics plc
-70.8 M
LAST VALUE
34.58%
2 YEAR CAGR
12.39%
5 YEAR CAGR
-17.29%
10 YEAR CAGR